[VPr] Vice President Lecture

[VPr-1] Transmission of prion and prion-like proteins in humans: an emerging concept of “acquired CAA”

^○Masahito Yamada (Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences)

Dr. Masahito Yamada, MD, PhD, is Professor and Chair in the Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Sciences, and Director of Neurological Clinic, Kanazawa University Hospital, Kanazawa, Japan. Dr. Yamada graduated from Tokyo Medical and Dental University School of Medicine in 1980, and had training in neurology, pathology, and neuroscience in Tokyo Medical and Dental University, its affiliated hospitals, and the University of California at San Diego. He became Associate Professor of Neurology at Tokyo Medical and Dental University in 1999, and Professor of Neurology at Kanazawa University School of Medicine in 2000. His clinical and research interest is in (1) brain aging, dementia, and amyloid (Alzheimer’s disease, cerebral amyloid angiopathy, etc.) and (2) infection and immunity of the nervous system (prion diseases, etc.). He has been the Chair of Research Committees on Amyloidosis (2005-2011) and on Prion Diseases (2011-) by the Ministry of Health, Labour and Welfare, Japan. He is also the Chair of Dementia Section in the Japanese Society of Neurology (JSN). He received the Japanese Society of Neuropathology (JSNP) Award (1996), the Sugita Genpaku Award (2018), the JSN Award (2020), the Catalyst Award of the U.S. National Academy of Medicine (NAM) Healthy Longevity Global Grand Challenge (2020), etc.